LUCILE GREGG to Humans
This is a "connection" page, showing publications LUCILE GREGG has written about Humans.
Connection Strength
0.504
-
Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb; 85(2):226-235.e1.
Score: 0.025
-
Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD. Clin J Am Soc Nephrol. 2023 11 01; 18(11):1479-1482.
Score: 0.023
-
Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders? Nephrol Dial Transplant. 2023 05 31; 38(6):1355-1365.
Score: 0.023
-
Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease. Am J Nephrol. 2023; 54(3-4):126-135.
Score: 0.023
-
Measurement of Fatigue in Patients Receiving Kidney Replacement Therapy. Am J Kidney Dis. 2023 07; 82(1):7-10.
Score: 0.023
-
Fatigue in Patients Receiving Maintenance Hemodialysis: A Review. Am J Kidney Dis. 2023 10; 82(4):464-480.
Score: 0.023
-
Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD. Am J Kidney Dis. 2023 07; 82(1):53-62.e1.
Score: 0.023
-
Revisiting diuretic choice in chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):406-413.
Score: 0.022
-
Diagnosis and Management of Depression in Patients With Kidney Disease. Semin Nephrol. 2021 11; 41(6):505-515.
Score: 0.021
-
Considerations in the Study of Body Mass Index Variability. J Am Soc Nephrol. 2021 10; 32(10):2395-2397.
Score: 0.021
-
Are All SGLT2 Inhibitors Created Equal? Clin J Am Soc Nephrol. 2021 09; 16(9):1309-1311.
Score: 0.020
-
Early eGFR decline after SGLT2i initiation: knowns and unknowns. Kidney Int. 2021 03; 99(3):548-550.
Score: 0.020
-
Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959.
Score: 0.020
-
Pharmacologic and psychological interventions for depression treatment in patients with kidney disease. Curr Opin Nephrol Hypertens. 2020 09; 29(5):457-464.
Score: 0.019
-
Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD. Kidney360. 2020 06 25; 1(6):436-446.
Score: 0.019
-
Inflammation and Response to Sertraline Treatment in Patients With CKD and Major Depression. Am J Kidney Dis. 2020 03; 75(3):457-460.
Score: 0.018
-
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes. Am J Nephrol. 2019; 50(1):37-47.
Score: 0.018
-
Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease. Am J Nephrol. 2018; 47(6):395-405.
Score: 0.016
-
Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data? Am J Kidney Dis. 2018 11; 72(5):728-744.
Score: 0.016
-
Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes. J Am Heart Assoc. 2017 Jul 05; 6(7).
Score: 0.015
-
Notification for sexually transmitted infections and HIV among sex workers in Guatemala: acceptability, barriers, and preferences. Sex Transm Dis. 2012 Jul; 39(7):504-8.
Score: 0.011
-
Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Res Care. 2021 07; 9(1).
Score: 0.010
-
Specific Gravity Improves Identification of Clinically Significant Quantitative Proteinuria from the Dipstick Urinalysis. Kidney360. 2024 Jun 01; 5(6):851-859.
Score: 0.006
-
Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study. Cardiorenal Med. 2024; 14(1):34-44.
Score: 0.006
-
The COVID-19 Pandemic: A Special Challenge for the Journal's Editors. J Am Soc Nephrol. 2023 12 01; 34(12):1945-1947.
Score: 0.006
-
Validation of a predictive model for hospital-acquired acute kidney injury with emergence of SARS-CoV-2 variants. J Investig Med. 2023 06; 71(5):459-464.
Score: 0.006
-
Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol. BMC Nephrol. 2022 10 12; 23(1):331.
Score: 0.006
-
Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index. Int J Obes (Lond). 2022 10; 46(10):1910-1917.
Score: 0.005
-
Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19. BMC Nephrol. 2022 02 01; 23(1):50.
Score: 0.005
-
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. Am Heart J. 2022 06; 248:160-162.
Score: 0.005
-
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. Clin J Am Soc Nephrol. 2022 02; 17(2):283-285.
Score: 0.005
-
The associations between orthostatic blood pressure changes and extracellular volume in hemodialysis patients. Hemodial Int. 2022 01; 26(1):124-133.
Score: 0.005
-
Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease. Nephrol Dial Transplant. 2021 07 23; 36(8):1546-1548.
Score: 0.005
-
Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1.
Score: 0.005
-
Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment. Clin J Am Soc Nephrol. 2021 09; 16(9):1445-1455.
Score: 0.005
-
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. JAMA. 2017 11 21; 318(19):1876-1890.
Score: 0.004